G1 Therapeutics (GTHX) stock forecast for 2023

The forecast has been updated: October 2, 2022 12:23


G1 Therapeutics stock price online today

Analyst Target Price

35.43

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell G1 Therapeutics stock stock today? What is the projected target price level for 2023? How much will it cost in 2023? G1 Therapeutics stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2023.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $35.43 target price for G1 Therapeutics stock stock.

Today 200 Day Moving Average is the support level (8.95 $).

50 Day Moving Average is the support level (12.65 $).




GTHX Forecast for 2023

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 9.58 7.67 10.67 28.13 %
Feb 8.81 7.45 9.57 22.12 %
Mar 8.07 6.74 9.81 31.31 %
Apr 9.01 8.52 10.49 18.78 %
May 10.61 9.81 11.47 14.49 %
Jun 11.01 9.76 12.76 23.52 %
Jul 10.51 9.48 11.78 19.50 %
Aug 10.68 9.44 11.54 18.23 %
Sep 11.34 9.38 12.53 25.16 %
Oct 12.69 10.60 14.23 25.52 %
Nov 11.49 9.13 13.60 32.85 %
Dec 11.67 10.07 12.62 20.23 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of G1 Therapeutics stock.


G1 Therapeutics overview

G1 Therapeutics Address

79 T.W. ALEXANDER DRIVE, 4501 RESEARCH COMMONS, SUITE 100, RESEARCH TRIANGLE PARK, NC, US

Market Capitalization

533 908 000 $

EBITDA

-161 988 000

PE Ratio

None

PEG Ratio

0

Dividend Per Share

0

Dividend Yield

0

EPS

-4.032

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

0.601

Trailing PE

-

Forward PE

-

EV To Revenue

16.79

EV To EBITDA

-2.908

52 Week High

17.49

52 Week Low

3.84

50 Day Moving Average

12.65

200 Day Moving Average

8.95

Shares Outstanding

42746800

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

G1 Therapeutics stock forecast for this year


G1 Therapeutics stock forecast for Jan 2023.
Estimated Average Forecasted G1 Therapeutics Price: 9.58. Negative monthly dynamics of the instrument is expected with 28.130% volatility is expected.

Pessimistic forecast: 7.67

Optimistic: 10.67


G1 Therapeutics stock forecast for Feb 2023.
Estimated Average Forecasted G1 Therapeutics Price: 8.81. Negative monthly dynamics of the instrument is expected with 22.119% volatility is expected.

Pessimistic forecast: 7.45

Optimistic: 9.57


G1 Therapeutics stock forecast for Mar 2023.
Estimated Average Forecasted G1 Therapeutics Price: 8.07. Negative monthly dynamics of the instrument is expected with 31.308% volatility is expected.

Pessimistic forecast: 6.74

Optimistic: 9.81


G1 Therapeutics stock forecast for Apr 2023.
Estimated Average Forecasted G1 Therapeutics Price: 9.01. Positive monthly dynamics of the instrument is expected with 18.778% volatility is expected.

Pessimistic forecast: 8.52

Optimistic: 10.49


G1 Therapeutics stock forecast for May 2023.
Estimated Average Forecasted G1 Therapeutics Price: 10.61. Positive monthly dynamics of the instrument is expected with 14.486% volatility is expected.

Pessimistic forecast: 9.81

Optimistic: 11.47


G1 Therapeutics stock forecast for Jun 2023.
Estimated Average Forecasted G1 Therapeutics Price: 11.01. Positive monthly dynamics of the instrument is expected with 23.523% volatility is expected.

Pessimistic forecast: 9.76

Optimistic: 12.76


G1 Therapeutics stock forecast for Jul 2023.
Estimated Average Forecasted G1 Therapeutics Price: 10.51. Negative monthly dynamics of the instrument is expected with 19.501% volatility is expected.

Pessimistic forecast: 9.48

Optimistic: 11.78


G1 Therapeutics stock forecast for Aug 2023.
Estimated Average Forecasted G1 Therapeutics Price: 10.68. Positive monthly dynamics of the instrument is expected with 18.233% volatility is expected.

Pessimistic forecast: 9.44

Optimistic: 11.54


G1 Therapeutics stock forecast for Sep 2023.
Estimated Average Forecasted G1 Therapeutics Price: 11.34. Positive monthly dynamics of the instrument is expected with 25.161% volatility is expected.

Pessimistic forecast: 9.38

Optimistic: 12.53


G1 Therapeutics stock forecast for Oct 2023.
Estimated Average Forecasted G1 Therapeutics Price: 12.69. Positive monthly dynamics of the instrument is expected with 25.519% volatility is expected.

Pessimistic forecast: 10.60

Optimistic: 14.23


G1 Therapeutics stock forecast for Nov 2023.
Estimated Average Forecasted G1 Therapeutics Price: 11.49. Negative monthly dynamics of the instrument is expected with 32.849% volatility is expected.

Pessimistic forecast: 9.13

Optimistic: 13.60


G1 Therapeutics stock forecast for Dec 2023.
Estimated Average Forecasted G1 Therapeutics Price: 11.67. Positive monthly dynamics of the instrument is expected with 20.231% volatility is expected.

Pessimistic forecast: 10.07

Optimistic: 12.62



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 103.08 (04.10.2022) 3.58 %
AbbVie Inc.
ABBV 141.99 (04.10.2022) 2.65 %
Aeterna Zentaris Inc.
AEZS 4.015 (04.10.2022) 7.07 %
Allakos Inc.
ALLK 6.74 (04.10.2022) 7.84 %
Allogene Therapeutics, Inc.
ALLO 11 (04.10.2022) 3.09 %
Amgen Inc.
AMGN 233.02 (04.10.2022) 1.12 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 4.22 (04.10.2022) 9.61 %
Aurora Cannabis Inc.
ACB 1.28 (04.10.2022) 4.07 %
Becton Dickinson and Company
BDX 236.97 (04.10.2022) 2.68 %
Biogen Inc.
BIIB 267.45 (04.10.2022) 1.19 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 8.3 (04.10.2022) -94.53 %
BioNTech SE
BNTX 137.57 (04.10.2022) 0.65 %
bluebird bio, Inc.
BLUE 6.79 (04.10.2022) 10.77 %
Boston Scientific Corp.
BSX 41.03 (04.10.2022) 2.88 %
Bristol-Myers Squibb Company
BMY 71.21 (04.10.2022) 0.96 %
Canopy Growth Corp.
CGC 3.14 (04.10.2022) 7.90 %
Castle Biosciences, Inc.
CSTL 30 (04.10.2022) 8.03 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 242.27 (04.02.2022) 0.00 %
Emergent BioSolutions Inc.
EBS 21.42 (04.10.2022) 1.66 %
Exelixis, Inc.
EXEL 18.56 (17.06.2022) 5.63 %
G1 Therapeutics, Inc.
GTHX 12.8 (04.10.2022) 3.14 %
Gilead Sciences, Inc.
GILD 65.31 (04.10.2022) 4.80 %
GlaxoSmithKline plc
GSK 30.71 (04.10.2022) 1.52 %
GoodRx Holdings, Inc.
GDRX 5.32 (04.10.2022) 8.13 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 69.56 (04.10.2022) 1.06 %
Inovio Pharmaceuticals, Inc.
INO 1.79 (05.10.2022) -2.19 %
Johnson & Johnson
JNJ 165.62 (04.10.2022) 1.48 %
Medtronic plc.
MDT 84.5 (04.10.2022) 2.18 %
Merck & Co., Inc.
MRK 88.39 (04.10.2022) 0.96 %
Moderna, Inc.
MRNA 125.67 (04.10.2022) 3.87 %
Novartis AG
NVS 78.23 (04.10.2022) 2.03 %
Novavax, Inc.
NVAX 19.4 (04.10.2022) 4.30 %
ObsEva SA
OBSV 0.1698 (04.10.2022) 10.19 %
OrganiGram Holdings Inc.
OGI 0.9049 (05.10.2022) -2.33 %
Pfizer Inc.
PFE 44.46 (04.10.2022) 0.72 %
Regeneron Pharmaceuticals, Inc.
REGN 739.54 (04.10.2022) 0.60 %
Sanofi
SNY 40.12 (04.10.2022) 2.37 %
Schrodinger, Inc.
SDGR 26.38 (04.10.2022) 4.77 %
Senseonics Holdings, Inc.
SENS 1.34 (04.10.2022) 2.29 %
Sorrento Therapeutics, Inc.
SRNE 1.65 (04.10.2022) 6.45 %
Stryker Corp.
SYK 215.8 (04.10.2022) 2.84 %
Sundial Growers Inc.
SNDL 2.3 (04.10.2022) 4.07 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.83 (04.10.2022) 7.29 %
Thermo Fisher Scientific Inc.
TMO 539.93 (04.10.2022) 3.25 %
Tilray, Inc.
TLRY 3 (04.10.2022) 4.53 %
UnitedHealth Group, Inc.
UNH 523.17 (04.10.2022) 1.49 %
Veeva Systems Inc.
VEEV 172.74 (04.10.2022) 3.62 %
Zomedica Corp.
ZOM 0.211 (04.10.2022) 0.52 %
Zynerba Pharmaceuticals, Inc.
ZYNE 0.76 (04.10.2022) -2.07 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.